Codis, a CDMO focused on commercial spray drying, amorphous solid dispersions (ASD), particle engineering, and finished-dose manufacturing, announces a growth investment from 1315 Capital, with participation from existing shareholders BroadOak Capital Partners and Research Corporation Technologies (RCT). The funding will accelerate expansion of Codis’s commercial manufacturing capacity, with a focus on its Haverhill, UK facility. Codis operates more than 400,000 square feet of cGMP facilities across St. Louis, MO; Seymour, IN; and Haverhill, UK, providing large-scale spray drying and related technologies for pharmaceutical, consumer health, nutraceutical, and OTC markets.
Read the full article: Codis Raises Growth Capital to Expand Commercial Manufacturing; Welcomes 1315 Capital //
Source: https://www.prnewswire.com/news-releases/codis-raises-growth-capital-to-expand-commercial-manufacturing-welcomes-1315-capital-302586560.html